HT-0712
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about HT-0712?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
HT-0712, also known as IPL-455903,[1] is an experimental cognitive enhancing drug (nootropic) which is currently undergoing clinical trials. It is currently being licensed by Helicon Therapeutics in San Diego, California. It was originally discovered and tested as part of a preclinical anti-inflammatory program by Inflazyme Pharmaceuticals.[2]
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | HT-0712, IPL 455,903 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H31NO3 |
Molar mass | 393.527 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close